![]() | |
Names | |
---|---|
Preferred IUPAC name 2-Propylpentanamide[1] | |
Identifiers | |
3D model (JSmol) | |
ChEBI | |
ChEMBL | |
ChemSpider |
|
DrugBank |
|
ECHA InfoCard | 100.017.632![]() |
EC Number |
|
KEGG |
|
MeSH | dipropylacetamide |
UNII | |
| |
| |
Properties | |
C8H17NO | |
Molar mass | 143.230 g·mol−1 |
Appearance | White crystals |
Melting point | 125 °C (257 °F; 398 K) |
logP | 2.041 |
Pharmacology | |
N03AG02 (WHO) | |
Hazards | |
GHS labelling: | |
![]() | |
Warning | |
H302 | |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose) |
|
Related compounds | |
Relatedamides | Valnoctamide |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). |
Valpromide (marketed asDepamide bySanofi-Aventis) is acarboxamide derivative ofvalproic acid used in the treatment ofepilepsy and someaffective disorders. It is rapidly metabolised (80%) tovalproic acid (anotheranticonvulsant) but has anticonvulsant properties itself. It may produce more stable plasma levels than valproic acid orsodium valproate and may be more effective at preventing febrile seizures. However, it is over one hundred times more potent as an inhibitor of liver microsomalepoxide hydrolase. This makes it incompatible withcarbamazepine and can affect the ability of the body to remove other toxins. Valpromide is no safer during pregnancy than valproic acid.
Valpromide is formed through the reaction of valproic acid andammonia via an intermediateacid chloride.
In pure form, valpromide is a white crystalline powder and has a melting point 125–126 °C. It is soluble only in hot water. It is available on the market in some European countries.
![]() | Thisanticonvulsant-related article is astub. You can help Wikipedia byexpanding it. |